Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 21Leukemia, Myeloid, Acute 16Lymphoma 15Leukemia 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Multiple Myeloma 13Lymphoma, Non-Hodgkin 13Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Follicular 12Hodgkin Disease 12Lymphoma, Mantle-Cell 9Lymphoma, Large B-Cell, Diffuse 8Lymphoma, B-Cell, Marginal Zone 8Graft vs Host Disease 8Neoplasms, Plasma Cell 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Myeloid, Accelerated Phase 7Congenital Abnormalities 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Myeloproliferative Disorders 6Leukemia, Myeloid, Chronic-Phase 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Burkitt Lymphoma 6Blast Crisis 6Waldenstrom Macroglobulinemia 5Primary Myelofibrosis 5Myelodysplastic-Myeloproliferative Diseases 5Lymphoma, Large-Cell, Anaplastic 5Leukemia, Prolymphocytic 5Hematologic Neoplasms 5

Interventions

fludarabine 1epratuzumab 1Thalidomide 1Tacrolimus 1Stem Cell Transplantation 1Melphalan 1Etoposide 1Doxorubicin 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1Calcium Dobesilate 1Busulfan 1Bortezomib 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Paraproteinemias × Tacrolimus × Clear all
NCT00579111 2016-05-04

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Baylor College of Medicine

Phase 1/2 Terminated
4 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hematologic Diseases, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Paraproteinemias, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡